Human trials on dysregulated nutrient sensing via the mTOR pathway showed significant results, including a 50% reduction in infections after an 8-week treatment. The study by Joan Mannick demonstrated lasting effects for a year. This advances longevity and health research.

Trial Details

The intervention targeted the mTOR pathway, leading to improved immune responses in participants.

Broader Impact

Such findings could influence treatments for age-related diseases, as discussed in recent posts on X.

Source: Posts found on X.